Review

human oct 1 pou2f1 plasmid (OriGene)

OriGene is a verified supplier

OriGene manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

OriGene human oct 1 pou2f1 plasmid

( a ) Representative western blot of stable HT29 line transduced with shSAE2 lentivirus showed lower <t>SAE2,</t> <t>Oct-1</t> and ALDH1A1 protein levels than HT29 transduced with control non-silencing shRNA (shCtrl); GAPDH, loading control. Right panel: quantification of band intensity. ( b ) SAE2 knockdown decreased and SAE2 overexpression increased the occupancy of Oct-1 on the ALDH1A1 promoter as measured by ChIP assay. ( c ) SAE2 knockdown did not affect Oct-1 transcription as shown by real-time quantitative PCR measurement of mRNA of HT29 shCtrl and shSAE2 cells. ( d ) Representative western blot showing SAE2 knockdown reduced Oct-1 stability, as shown by treatment with 100 μg ml −1 CHX to block protein synthesis in HT29 shCtrl and shSAE2 cells; GAPDH, loading control. Quantification of band intensities (Oct-1 decay curve) in three independent experiments is shown below. ( e ) Representative western blot showing SAE2 knockdown-enhanced Oct-1 ubiquitination. HT29 shCtrl or shSAE2 cells were treated with or without proteasome inhibitor MG132 (10 μM) for 8 h, and IP was carried out using cell lysates, followed by western blot with an anti-Oct-1 or anti-ubiquitin antibody. NS, not significant; *** P <0.001.

Human Oct 1 Pou2f1 Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+oct+1+pou2f1+plasmid/Oct-1+(POU2F1)+(NM_001198783)+Human+Tagged+ORF+Clone/pmc04974481-163-1-8
Average 90 stars, based on 1 article reviews

human oct 1 pou2f1 plasmid - by Bioz Stars, 2026-11

90/100 stars

Images

1) Product Images from "Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal"

Article Title: Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal

Journal: Nature Communications

doi: 10.1038/ncomms12326

( a ) Representative western blot of stable HT29 line transduced with shSAE2 lentivirus showed lower SAE2, Oct-1 and ALDH1A1 protein levels than HT29 transduced with control non-silencing shRNA (shCtrl); GAPDH, loading control. Right panel: quantification of band intensity. ( b ) SAE2 knockdown decreased and SAE2 overexpression increased the occupancy of Oct-1 on the ALDH1A1 promoter as measured by ChIP assay. ( c ) SAE2 knockdown did not affect Oct-1 transcription as shown by real-time quantitative PCR measurement of mRNA of HT29 shCtrl and shSAE2 cells. ( d ) Representative western blot showing SAE2 knockdown reduced Oct-1 stability, as shown by treatment with 100 μg ml −1 CHX to block protein synthesis in HT29 shCtrl and shSAE2 cells; GAPDH, loading control. Quantification of band intensities (Oct-1 decay curve) in three independent experiments is shown below. ( e ) Representative western blot showing SAE2 knockdown-enhanced Oct-1 ubiquitination. HT29 shCtrl or shSAE2 cells were treated with or without proteasome inhibitor MG132 (10 μM) for 8 h, and IP was carried out using cell lysates, followed by western blot with an anti-Oct-1 or anti-ubiquitin antibody. NS, not significant; *** P <0.001.

Figure Legend Snippet: ( a ) Representative western blot of stable HT29 line transduced with shSAE2 lentivirus showed lower SAE2, Oct-1 and ALDH1A1 protein levels than HT29 transduced with control non-silencing shRNA (shCtrl); GAPDH, loading control. Right panel: quantification of band intensity. ( b ) SAE2 knockdown decreased and SAE2 overexpression increased the occupancy of Oct-1 on the ALDH1A1 promoter as measured by ChIP assay. ( c ) SAE2 knockdown did not affect Oct-1 transcription as shown by real-time quantitative PCR measurement of mRNA of HT29 shCtrl and shSAE2 cells. ( d ) Representative western blot showing SAE2 knockdown reduced Oct-1 stability, as shown by treatment with 100 μg ml −1 CHX to block protein synthesis in HT29 shCtrl and shSAE2 cells; GAPDH, loading control. Quantification of band intensities (Oct-1 decay curve) in three independent experiments is shown below. ( e ) Representative western blot showing SAE2 knockdown-enhanced Oct-1 ubiquitination. HT29 shCtrl or shSAE2 cells were treated with or without proteasome inhibitor MG132 (10 μM) for 8 h, and IP was carried out using cell lysates, followed by western blot with an anti-Oct-1 or anti-ubiquitin antibody. NS, not significant; *** P <0.001.

Techniques Used: Western Blot, Transduction, shRNA, Over Expression, Real-time Polymerase Chain Reaction, Blocking Assay

( a ) Mass spectrometry identified TRIM21 as an Oct-1-interacting protein. Representative silver stain of HCT116 cells transfected with Flag-tagged Oct-1 or empty vector (Ctrl) for 2 days, lysed and immunoprecipitated with anti-Flag antibody-conjugated M2 beads. Proteins identified in each group are indicated in the graphic. ( b ) Representative IP-western blot analysis of the interaction between endogenous TRIM21 and Oct-1 in HT29 cells. ( c ) Knockdown of TRIM21 delayed Oct-1 degradation. Representative western blot of Oct-1 level over time in HT29 cells transfected with control non-silencing siRNA (siCtrl) or siTRIM21 for 3 days, followed by 100 μg ml −1 CHX treatment; GAPDH, loading control. Oct-1 decay curve (right panel) was determined by quantifying three independent experiments. ( d ) TRIM21 knockdown resulted in increased Oct-1 protein level and decreased ubiquitination of Oct-1. Representative western blot of HT29 cells transfected with siCtrl and siTRIM21 treated with or without 10 μM MG132 for 8 h. IP was carried out with cell lysates, and Oct-1, TRIM21 and ubiquitin were detected; GAPDH, loading control. ( e ) Overexpression of TRIM21 decreased Oct-1 and increased Oct-1 ubiquitination in cells. Representative western blot of HT29 cells were transfected with empty vector (Ctrl) or Flag-TRIM21 for 2 days, then treated with or without 10 μM MG132 for 8 h. IP was carried out with cell lysates, and western blot was performed to detect Oct-1, TRIM21 and ubiquitin; GAPDH, loading control.

Figure Legend Snippet: ( a ) Mass spectrometry identified TRIM21 as an Oct-1-interacting protein. Representative silver stain of HCT116 cells transfected with Flag-tagged Oct-1 or empty vector (Ctrl) for 2 days, lysed and immunoprecipitated with anti-Flag antibody-conjugated M2 beads. Proteins identified in each group are indicated in the graphic. ( b ) Representative IP-western blot analysis of the interaction between endogenous TRIM21 and Oct-1 in HT29 cells. ( c ) Knockdown of TRIM21 delayed Oct-1 degradation. Representative western blot of Oct-1 level over time in HT29 cells transfected with control non-silencing siRNA (siCtrl) or siTRIM21 for 3 days, followed by 100 μg ml −1 CHX treatment; GAPDH, loading control. Oct-1 decay curve (right panel) was determined by quantifying three independent experiments. ( d ) TRIM21 knockdown resulted in increased Oct-1 protein level and decreased ubiquitination of Oct-1. Representative western blot of HT29 cells transfected with siCtrl and siTRIM21 treated with or without 10 μM MG132 for 8 h. IP was carried out with cell lysates, and Oct-1, TRIM21 and ubiquitin were detected; GAPDH, loading control. ( e ) Overexpression of TRIM21 decreased Oct-1 and increased Oct-1 ubiquitination in cells. Representative western blot of HT29 cells were transfected with empty vector (Ctrl) or Flag-TRIM21 for 2 days, then treated with or without 10 μM MG132 for 8 h. IP was carried out with cell lysates, and western blot was performed to detect Oct-1, TRIM21 and ubiquitin; GAPDH, loading control.

Techniques Used: Mass Spectrometry, Silver Staining, Transfection, Plasmid Preparation, Immunoprecipitation, Western Blot, Over Expression

( a ) Representative IHC staining indicates higher TRIM21 level corresponding with lower Oct-1 in shSAE2 group tumour tissue compared with shCtrl group (scale bar, 100 μm). Tumour tissues were from LDA assay described in . ( b ) Western blot (left) and quantification of SAE2, Oct-1, TRIM21 and ALDH levels in the same tumour tissues as a ; GAPDH, loading control. ‘1, 2 and 3' indicate tumour tissues from different mouse. ( c ) TRIM21 promoter activity was inhibited by overexpression of SAE2 and Ubc9 but increased by SENP1 overexpression as determined by luciferase reporter assay. HT29 cells were transfected with empty vector (Ctrl) or SAE2, UBC9 or SENP1 expression plasmid together with TRIM21 promoter luciferase reporter and Renilla plasmids. Dual-luciferase activity was measured after 48 h and normalized results were analysed with two-tailed Student's t -test. ( d ) TRIM21 mRNA level was suppressed by SAE2 or Ubc9 overexpression and enhanced with SENP1 overexpression in HT29 cells as determined by quantitative PCR (qPCR). ( e ) IRF1 SUMOylation site mutant K78R induced higher TRIM21 mRNA level than wild-type (WT) IRF1 as determined by qPCR. ( f ) TRIM21 protein level was suppressed on SAE2 or Ubc9 overexpression but enhanced with SENP1 overexpression as indicated by western blot; GAPDH, loading control. ( g ) Western blot showed overexpression of K78R mutant-induced higher TRIM21 protein level than WT IRF1 in shCtrl HT29 cells; GAPDH, loading control. * P <0.05, ** P <0.01 and *** P <0.001.

Figure Legend Snippet: ( a ) Representative IHC staining indicates higher TRIM21 level corresponding with lower Oct-1 in shSAE2 group tumour tissue compared with shCtrl group (scale bar, 100 μm). Tumour tissues were from LDA assay described in . ( b ) Western blot (left) and quantification of SAE2, Oct-1, TRIM21 and ALDH levels in the same tumour tissues as a ; GAPDH, loading control. ‘1, 2 and 3' indicate tumour tissues from different mouse. ( c ) TRIM21 promoter activity was inhibited by overexpression of SAE2 and Ubc9 but increased by SENP1 overexpression as determined by luciferase reporter assay. HT29 cells were transfected with empty vector (Ctrl) or SAE2, UBC9 or SENP1 expression plasmid together with TRIM21 promoter luciferase reporter and Renilla plasmids. Dual-luciferase activity was measured after 48 h and normalized results were analysed with two-tailed Student's t -test. ( d ) TRIM21 mRNA level was suppressed by SAE2 or Ubc9 overexpression and enhanced with SENP1 overexpression in HT29 cells as determined by quantitative PCR (qPCR). ( e ) IRF1 SUMOylation site mutant K78R induced higher TRIM21 mRNA level than wild-type (WT) IRF1 as determined by qPCR. ( f ) TRIM21 protein level was suppressed on SAE2 or Ubc9 overexpression but enhanced with SENP1 overexpression as indicated by western blot; GAPDH, loading control. ( g ) Western blot showed overexpression of K78R mutant-induced higher TRIM21 protein level than WT IRF1 in shCtrl HT29 cells; GAPDH, loading control. * P <0.05, ** P <0.01 and *** P <0.001.

Techniques Used: Immunohistochemistry, Western Blot, Activity Assay, Over Expression, Luciferase, Reporter Assay, Transfection, Plasmid Preparation, Expressing, Two Tailed Test, Real-time Polymerase Chain Reaction, Mutagenesis

( a ) Overexpression of Oct-1 partially compensated for the reduction of CSC frequency by SAE2 knockdown in HT29 cells as determined by LDA. Stable cell lines were generated with lentivirus expressing pLenti CMV-hygro empty vector (EV) or pLenti CMV-Flag-Oct-1 in HT29 shCtrl and shSAE2 cells as shCtrl+EV, shSAE2+EV and shSAE2+Oct-1. ( b ) Representative western blot of the stable lines to confirm expression with Oct-1 and Flag-tag antibodies; GAPDH, loading control. ( c ) Overexpression of Oct-1 in SAE2 or Ubc9 knockdown cells restored ALDH + cells population in HT29 cells as measured by FACS analysis using the AldeFluor kit. HT29 cells were transfected with control non-targeting siRNA (SiCtrl), SAE2-targeting siRNA (SiSAE2) or Ubc9-targeting siRNA (SiUbc9) followed by Flag-Oct-1 plasmid or control empty vector transfection. After 3 days, cells were collected for FACS analysis using the AldeFluor kit. ( d ) Representative western blot of the samples from c ; quantification of the ALDH1A1 band intensity is shown on the bottom. ( e ) Knockdown of Ubc9 reduced CSC frequency, as shown by LDA using spheroid formation using HT29 stable cell lines expressing two different UBC9-targeting shRNA (shUBC9#1 and shUBC9#2). ( f ) Schematic diagram showing the mechanism of how SUMOylation regulates CSCs through Oct-1, TRIM21 and IRF1. * P <0.05, ** P <0.01 and *** P <0.001.

Figure Legend Snippet: ( a ) Overexpression of Oct-1 partially compensated for the reduction of CSC frequency by SAE2 knockdown in HT29 cells as determined by LDA. Stable cell lines were generated with lentivirus expressing pLenti CMV-hygro empty vector (EV) or pLenti CMV-Flag-Oct-1 in HT29 shCtrl and shSAE2 cells as shCtrl+EV, shSAE2+EV and shSAE2+Oct-1. ( b ) Representative western blot of the stable lines to confirm expression with Oct-1 and Flag-tag antibodies; GAPDH, loading control. ( c ) Overexpression of Oct-1 in SAE2 or Ubc9 knockdown cells restored ALDH + cells population in HT29 cells as measured by FACS analysis using the AldeFluor kit. HT29 cells were transfected with control non-targeting siRNA (SiCtrl), SAE2-targeting siRNA (SiSAE2) or Ubc9-targeting siRNA (SiUbc9) followed by Flag-Oct-1 plasmid or control empty vector transfection. After 3 days, cells were collected for FACS analysis using the AldeFluor kit. ( d ) Representative western blot of the samples from c ; quantification of the ALDH1A1 band intensity is shown on the bottom. ( e ) Knockdown of Ubc9 reduced CSC frequency, as shown by LDA using spheroid formation using HT29 stable cell lines expressing two different UBC9-targeting shRNA (shUBC9#1 and shUBC9#2). ( f ) Schematic diagram showing the mechanism of how SUMOylation regulates CSCs through Oct-1, TRIM21 and IRF1. * P <0.05, ** P <0.01 and *** P <0.001.

Techniques Used: Over Expression, Stable Transfection, Generated, Expressing, Plasmid Preparation, Western Blot, FLAG-tag, Transfection, shRNA

Plasmid Preparation:

Article Title: Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal
Article Snippet: Two GIPZ shRNA-eGFP vectors were purchased from GE Dharmacon, one with shRNA sequence targeting the open reading frame of UBC9 (shUBC9#1, Clone ID V2LHS_171776), the other with shRNA sequence targeting the 3′-untranslated region of UBC9 (shUBC9#2, Clone ID V2LHS_171781). pLenti CMV/TO hygro empty (w214-1) vector was obtained from Addgene. .. Myc-DDK-tagged human Oct-1 (POU2F1) plasmid was purchased from Origene. ..

Image Search Results

Journal: Nature Communications

Article Title: Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal

doi: 10.1038/ncomms12326

Figure Lengend Snippet: ( a ) Representative western blot of stable HT29 line transduced with shSAE2 lentivirus showed lower SAE2, Oct-1 and ALDH1A1 protein levels than HT29 transduced with control non-silencing shRNA (shCtrl); GAPDH, loading control. Right panel: quantification of band intensity. ( b ) SAE2 knockdown decreased and SAE2 overexpression increased the occupancy of Oct-1 on the ALDH1A1 promoter as measured by ChIP assay. ( c ) SAE2 knockdown did not affect Oct-1 transcription as shown by real-time quantitative PCR measurement of mRNA of HT29 shCtrl and shSAE2 cells. ( d ) Representative western blot showing SAE2 knockdown reduced Oct-1 stability, as shown by treatment with 100 μg ml −1 CHX to block protein synthesis in HT29 shCtrl and shSAE2 cells; GAPDH, loading control. Quantification of band intensities (Oct-1 decay curve) in three independent experiments is shown below. ( e ) Representative western blot showing SAE2 knockdown-enhanced Oct-1 ubiquitination. HT29 shCtrl or shSAE2 cells were treated with or without proteasome inhibitor MG132 (10 μM) for 8 h, and IP was carried out using cell lysates, followed by western blot with an anti-Oct-1 or anti-ubiquitin antibody. NS, not significant; *** P <0.001.

Article Snippet: Myc-DDK-tagged human Oct-1 (POU2F1) plasmid was purchased from Origene.

Techniques: Western Blot, Transduction, shRNA, Over Expression, Real-time Polymerase Chain Reaction, Blocking Assay

Journal: Nature Communications

Article Title: Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal

doi: 10.1038/ncomms12326

Figure Lengend Snippet: ( a ) Mass spectrometry identified TRIM21 as an Oct-1-interacting protein. Representative silver stain of HCT116 cells transfected with Flag-tagged Oct-1 or empty vector (Ctrl) for 2 days, lysed and immunoprecipitated with anti-Flag antibody-conjugated M2 beads. Proteins identified in each group are indicated in the graphic. ( b ) Representative IP-western blot analysis of the interaction between endogenous TRIM21 and Oct-1 in HT29 cells. ( c ) Knockdown of TRIM21 delayed Oct-1 degradation. Representative western blot of Oct-1 level over time in HT29 cells transfected with control non-silencing siRNA (siCtrl) or siTRIM21 for 3 days, followed by 100 μg ml −1 CHX treatment; GAPDH, loading control. Oct-1 decay curve (right panel) was determined by quantifying three independent experiments. ( d ) TRIM21 knockdown resulted in increased Oct-1 protein level and decreased ubiquitination of Oct-1. Representative western blot of HT29 cells transfected with siCtrl and siTRIM21 treated with or without 10 μM MG132 for 8 h. IP was carried out with cell lysates, and Oct-1, TRIM21 and ubiquitin were detected; GAPDH, loading control. ( e ) Overexpression of TRIM21 decreased Oct-1 and increased Oct-1 ubiquitination in cells. Representative western blot of HT29 cells were transfected with empty vector (Ctrl) or Flag-TRIM21 for 2 days, then treated with or without 10 μM MG132 for 8 h. IP was carried out with cell lysates, and western blot was performed to detect Oct-1, TRIM21 and ubiquitin; GAPDH, loading control.

Article Snippet: Myc-DDK-tagged human Oct-1 (POU2F1) plasmid was purchased from Origene.

Techniques: Mass Spectrometry, Silver Staining, Transfection, Plasmid Preparation, Immunoprecipitation, Western Blot, Over Expression

Journal: Nature Communications

Article Title: Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal

doi: 10.1038/ncomms12326

Figure Lengend Snippet: ( a ) Representative IHC staining indicates higher TRIM21 level corresponding with lower Oct-1 in shSAE2 group tumour tissue compared with shCtrl group (scale bar, 100 μm). Tumour tissues were from LDA assay described in . ( b ) Western blot (left) and quantification of SAE2, Oct-1, TRIM21 and ALDH levels in the same tumour tissues as a ; GAPDH, loading control. ‘1, 2 and 3' indicate tumour tissues from different mouse. ( c ) TRIM21 promoter activity was inhibited by overexpression of SAE2 and Ubc9 but increased by SENP1 overexpression as determined by luciferase reporter assay. HT29 cells were transfected with empty vector (Ctrl) or SAE2, UBC9 or SENP1 expression plasmid together with TRIM21 promoter luciferase reporter and Renilla plasmids. Dual-luciferase activity was measured after 48 h and normalized results were analysed with two-tailed Student's t -test. ( d ) TRIM21 mRNA level was suppressed by SAE2 or Ubc9 overexpression and enhanced with SENP1 overexpression in HT29 cells as determined by quantitative PCR (qPCR). ( e ) IRF1 SUMOylation site mutant K78R induced higher TRIM21 mRNA level than wild-type (WT) IRF1 as determined by qPCR. ( f ) TRIM21 protein level was suppressed on SAE2 or Ubc9 overexpression but enhanced with SENP1 overexpression as indicated by western blot; GAPDH, loading control. ( g ) Western blot showed overexpression of K78R mutant-induced higher TRIM21 protein level than WT IRF1 in shCtrl HT29 cells; GAPDH, loading control. * P <0.05, ** P <0.01 and *** P <0.001.

Article Snippet: Myc-DDK-tagged human Oct-1 (POU2F1) plasmid was purchased from Origene.

Techniques: Immunohistochemistry, Western Blot, Activity Assay, Over Expression, Luciferase, Reporter Assay, Transfection, Plasmid Preparation, Expressing, Two Tailed Test, Real-time Polymerase Chain Reaction, Mutagenesis

Journal: Nature Communications

Article Title: Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal

doi: 10.1038/ncomms12326

Figure Lengend Snippet: ( a ) Overexpression of Oct-1 partially compensated for the reduction of CSC frequency by SAE2 knockdown in HT29 cells as determined by LDA. Stable cell lines were generated with lentivirus expressing pLenti CMV-hygro empty vector (EV) or pLenti CMV-Flag-Oct-1 in HT29 shCtrl and shSAE2 cells as shCtrl+EV, shSAE2+EV and shSAE2+Oct-1. ( b ) Representative western blot of the stable lines to confirm expression with Oct-1 and Flag-tag antibodies; GAPDH, loading control. ( c ) Overexpression of Oct-1 in SAE2 or Ubc9 knockdown cells restored ALDH + cells population in HT29 cells as measured by FACS analysis using the AldeFluor kit. HT29 cells were transfected with control non-targeting siRNA (SiCtrl), SAE2-targeting siRNA (SiSAE2) or Ubc9-targeting siRNA (SiUbc9) followed by Flag-Oct-1 plasmid or control empty vector transfection. After 3 days, cells were collected for FACS analysis using the AldeFluor kit. ( d ) Representative western blot of the samples from c ; quantification of the ALDH1A1 band intensity is shown on the bottom. ( e ) Knockdown of Ubc9 reduced CSC frequency, as shown by LDA using spheroid formation using HT29 stable cell lines expressing two different UBC9-targeting shRNA (shUBC9#1 and shUBC9#2). ( f ) Schematic diagram showing the mechanism of how SUMOylation regulates CSCs through Oct-1, TRIM21 and IRF1. * P <0.05, ** P <0.01 and *** P <0.001.

Article Snippet: Myc-DDK-tagged human Oct-1 (POU2F1) plasmid was purchased from Origene.

Techniques: Over Expression, Stable Transfection, Generated, Expressing, Plasmid Preparation, Western Blot, FLAG-tag, Transfection, shRNA

Review

human oct 1 pou2f1 plasmid (OriGene)

Structured Review

Images

1) Product Images from "Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal"

Related Articles

Plasmid Preparation:

Similar Products

Image Search Results